Interestingly, tumor cells in EBV-associated cancers such as classical Hodgkin’s Lymphoma (cHL) and post-transplant lymphoproliferative disorders also express significant levels of PD-L1 [79] suggesting possible active manipulation of this pathway by EBV. Here, CD274 is linked to classic Hodgkin lymphoma.